Binding potencies of 3 new beta 2 specific blockers to beta receptors in the ciliary processes and the possible relevance of these drugs to intraocular pressure control.
Open Access
- 1 April 1984
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 68 (4) , 245-247
- https://doi.org/10.1136/bjo.68.4.245
Abstract
The binding potencies of 3 new beta 2 blocking drugs to beta receptors in the ciliary processes were studied by means of radioligand techniques. The drugs studied were IPS339, ICI118,551, and Sandoz L1 32-468. The order of potency of these drugs was IPS339 greater than Sandoz L1 32-468 greater than ICI118,551. The beta 2 dissociation constants (KDs) for these drugs were 0.90 nM, 6.60 nM, and 55 nM respectively. These results are compared with those for other adrenergic agents, including timolol. The potential role of topical beta 2 blockers in glaucoma is discussed.This publication has 5 references indexed in Scilit:
- Adrenergic Receptors in ManNew England Journal of Medicine, 1982
- Identification of beta-adrenergic receptors in the pigmented mammalian iris-ciliary body diaphragmExperimental Eye Research, 1982
- HUMAN CILIARY PROCESS ADRENERGIC-RECEPTOR - PHARMACOLOGICAL CHARACTERIZATION1981
- Adverse Reactions from Timolol AdministrationOphthalmology, 1980
- Ocular and cardiovascular effects of local and systemic pindolol.British Journal of Ophthalmology, 1979